An exploratory study of chemotherapy enhancement effects of mefenamic acid and cilostazol in patients with locally advanced head & neck cancer
Phase 2
- Conditions
- locally advanced head &neck cancer
- Registration Number
- JPRN-UMIN000007871
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1) Gastric ulcer 2) Severe hematological, hepatic, renal or cardiac disorder 3) History of severe hypersensitivity to the ingredients of an agent used in this study 4) Aspirin asthma or its history 5) Uncontrolled hypertension 6) History of diarrhea in the use of mefenamic acid or cilostazol 7) Receiving anticoagulant therapy 8) Bleeding or bleeding tendency 9) Congestive heart failure 10) Pregnant 11) Lactating women 12) Psychotic disorder 13) Receiving systemic steroid therapy 14) Patients with any other conditions whom the doctor determined to be inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method